Serum uric acid dynamics in chinese people with HIV: a 20-year retrospective cohort study
Serum uric acid (UA) abnormalities may represent an underrecognized metabolic concern in people with HIV (PWH). However, longitudinal UA dynamics following antiretroviral therapy (ART) initiation and their associations with treatment regimen and weight change remain insufficiently characterized. We conducted a retrospective cohort study of ART-naïve PWH who initiated ART within one month of enrollment at a tertiary hospital in Beijing between 2004 and 2024. Multivariable linear regression was used to identify factors associated with baseline UA. Long-term UA trajectories were examined using generalized estimating equations (GEE) among male participants receiving integrase strand transfer inhibitor (INSTI)- or non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART. Associations between six-month changes in body weight and UA were assessed using multivariable linear regression. Exploratory analyses examined CD4⁺ T cell recovery in relation to ART regimen and UA change. Among 463 participants with available baseline UA measurements, the median UA concentration was 366.5 µmol/L, and 27.6% had hyperuricemia. Higher baseline UA was independently associated with younger age, male sex, higher serum creatinine, higher CD4⁺ T cell count, and later recruitment year. Among male participants, long-term GEE analysis found no significant difference in the average rate of UA change between INSTI- and NNRTI-based ART ( P = 0.576). However, early UA changes differed significantly between regimens. Compared with NNRTI-based ART, INSTI-based ART was associated with greater increases in UA at 3 months (between-group difference, 35.9 µmol/L; 95% CI, 17.2–54.7), 6 months (47.2 µmol/L; 95% CI, 27.7–66.8), and 12 months (23.5 µmol/L; 95% CI, 5.0–42.0). Six-month weight gain was greater among INSTI recipients than NNRTI recipients (3.44 ± 4.30 vs. 1.30 ± 5.03 kg; P < 0.001). In multivariable analysis, each 1-kg increase in body weight was associated with a 3.08-µmol/L greater increase in UA (95% CI, 1.08–5.08; P = 0.003). Exploratory analyses showed greater six-month CD4⁺ T cell recovery among INSTI recipients, whereas UA change was not independently associated with CD4⁺ T cell recovery. In this cohort of Chinese PWH, baseline hyperuricemia was common, and early UA changes differed by ART regimen. INSTI-based ART was associated with greater early UA increases and greater weight gain, while weight change was independently associated with UA change. These findings support further investigation of the metabolic implications of ART initiation and the potential value of monitoring UA and weight during early treatment.
Authors
- Leidan Zhang
- Xin Huang (ORCID: https://orcid.org/0000-0002-2960-8349)
- liyuan Zheng
- Wei Lyu
- Xiaojing Song
- Taisheng Li
- Fada Wang
- Wei Cao
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1186/s12879-026-14845-8
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peking Union Medical College Hospital
- National Science and Technology Major Project
- National Health Commission of the People's Republic of China